White House At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials June 28, 2024Vol.50 No.26By McKenzie Prillaman
Clinical Roundup FDA guidance provides new details on diversity action plans for clinical studies June 28, 2024Vol.50 No.26
Cancer History ProjectFree Remembering the day 22 years ago when ODAC debated the Iressa quandary June 21, 2024Vol.50 No.25By Paul Goldberg
Drugs & Targets FDA approves Keytruda combination for primary advanced or recurrent endometrial carcinoma June 21, 2024Vol.50 No.25
Drugs & Targets FDA clears IND application for ZW171, a 2+1 T-cell targeting bispecific antibody for mesothelin-expressing cancers June 21, 2024Vol.50 No.25
Drugs & Targets FDA approves Breyanzi for relapsed or refractory mantle cell lymphoma June 14, 2024Vol.50 No.24
Drugs & Targets FDA grants accelerated approval to Augtyro for NTRK gene fusion-positive solid tumors June 14, 2024Vol.50 No.24
In Brief Harpreet Singh departs FDA, joins Precision for Medicine as chief medical officer June 07, 2024Vol.50 No.23
Drugs & Targets FDA approves imetelstat for low- to intermediate-1 risk MDS with transfusion-dependent anemia June 07, 2024Vol.50 No.23
